Hongqiang REN, Yijun LIU, Guiquan LUO, et al. Sphingosine-1-phosphate type 1 receptor aggravates neointimal hyperplasia after carotid artery injury in mice[J]. Journal of Third Military Medical University, 2021, 43(3): 202-210.
DOI:
Hongqiang REN, Yijun LIU, Guiquan LUO, et al. Sphingosine-1-phosphate type 1 receptor aggravates neointimal hyperplasia after carotid artery injury in mice[J]. Journal of Third Military Medical University, 2021, 43(3): 202-210. DOI: 10.16016/j.1000-5404.202009032.
Sphingosine-1-phosphate type 1 receptor aggravates neointimal hyperplasia after carotid artery injury in mice
To investigate the role and mechanism of sphingosine-1-phosphate type 1 receptor (S1PR1) in neointimal hyperplasia after carotid artery injury in mice.
Methods
2
A total of 40 C57BL/6 mice were rando
mly and equally subjected to 4 groups: sham operation+AAV-LacZ group
sham operation+AAV-S1PR1 group
model+AAV-LacZ group
and model+AAV-S1PR1 group. In 2 weeks after the delivery of AAV-LacZ or AAV-S1PR1 adenovirus to corresponding mice
via
tail vein injection
a mouse model of carotid artery injury was established with a flexible wire inserting into the common carotid artery. After 4 weeks
the carotid artery was harvested to measure the severity of neointimal hyperplasia by HE staining
the expression of α-smooth muscle actin (α-SMA) by immunofluorescence staining
and the levels of proliferating cell nuclear antigen (PCNA) and interleukin-6 (IL-6) by immunohistochemistry. In the isolated and primarily cultured mouse aortic vascular smooth muscle cells (VSMCs)
the adenovirus Ad-S1PR1 or Ad-LacZ were transfected respectively
and then the cells were incubated with 1 μmol/L S1P. The hallmarks of phenotypic switch of VSMCs were detected with Western blotting and immunofluorescence assay
cell proliferation with EdU staining
migration by scratch wound healing assay and transwell migration assay
and activation of IL-6/STAT3 pathway by Western blotting.
Results
2
In 4 weeks after model establishment
the mice of the model+AAV-LacZ group had obvious neointimal hyperplasia
phenotypic switch and cell proliferation (
P
<
0.05)
and significant upregulation of IL-6 in the carotid artery injury when compared with the mice of the sham operation+AAV-LacZ group. In the mice of the model+AAV-S1PR1 group
the level of S1PR1 was over-expressed (
P
<
0.05)
and above phenomena were aggravated when compared with the mice from the model+AAV-LacZ group (
P
<
0.05). In the
in vitro
study
S1P treatment induced the phenotypic switch
proliferation and migration
and activation of the IL-6/ STAT3 pathway in the primary VSMCs (
P
<
0.05)
and the pathophysiological changes above were further ag
gravated after the transfection of Ad-S1PR1 (
P
<
0.05).
Conclusion
2
S1P/S1PR1 can promote the phenotypic switch and proliferation and migration of VSMCs
and aggravate the intimal hyperplasia after vascular injury
which may be due to the activation of IL-6/STAT3 pathway.
关键词
Keywords
references
WEINTRAUB W S. The pathophysiology and burden of restenosis[J]. Am J Cardiol, 2007, 100(5): S3-S9. DOI:10.1016/j.amjcard.2007.06.002.
ZHANG S M, ZHU L H, CHEN H Z, et al . Interferon regulatory factor 9 is critical for neointima formation following vascular injury[J ] . Nat Commun, 2014, 5: 5160. DOI:10.1038/ncomms6160.
SANCHEZ T. Sphingosine-1-phosphate signaling in endothelial disorders[J]. Curr Atheroscler Rep, 2016, 18(6): 1-13. DOI:10.1007/s11883-016-0586-1.
VESTRI A, PIERUCCI F, FRATI A, et al . Sphingosine 1-phosphate receptors: do they have a therapeutic potential in cardiac fibrosis?[J ] . Front Pharmacol, 2017, 8: 296. DOI:10.3389/fphar.2017.00296.
ŻAK M M, GKONTRA P, CLEMENTE C, et al . Sequential bone-marrow cell delivery of VEGFA/S1P improves vascularizat ion and limits adverse cardiac remodeling after myocardial infarction in mice[J ] . Hum Gene Ther, 2019, 30(7): 893-905. DOI:10.1089/hum.2018.194.
DAI M, WU L, HE Z, et al . Epoxyeicosatrienoic acids regulate macrophage polarization and prevent LPS-induced cardiac dysfunction[J ] . J Cell Physiol, 2015, 230(9): 2108-2119. DOI:10.1002/jcp.24939.
TAKUWA Y. Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system[J]. Biochim et Biophys Acta BBA - Mol Cell Biol Lipids, 2008, 1781(9): 483-488. DOI:10.1016/j.bbalip.2008.04.003.
ZHANG D D, ZHANG Z C, WU R, et al . Effects and mechanisms of sphingosine-l-phosphate receptors in cardiovascular system[J ] . Chin J Arterioscler, 2013, 21(11): 1047-1052.
SHIMIZU T, NAKAZAWA T, CHO A, et al . Sphingosine 1-phosphate receptor 2 negatively regulates neointimal formation in mouse arteries[J ] . Circ Res, 2007, 101(10): 995-1000. DOI:10.1161/circresaha.107.159228.
O'BRIEN E R, MA X, SIMARD T, et al . Pathogenesis of neointima formation following vascular injury[J ] . Cardiovasc Hematol Disord Drug Targets, 2011, 11(1): 30-39. DOI:10.2174/187152911795945169.
MCDONALD O G, OWENS G K. Programming smooth muscle plasticity with chromatin dynamics[J]. Circ Res, 2007, 100(10): 1428-1441. DOI:10.1161/01.res.0000266448.30370.a0.
ZHANG F, XIA Y, YAN W, et al . Sphingosine 1-phosphate signaling contributes to cardiac inflammation, dysfunction, and remodeling following myocardial infarction[J ] . Am J Physiol Heart Circ Physiol, 2016, 310(2): H250-H261. DOI:10.1152/ajpheart.00372.2015.
PETERS S L, ALEWIJNSE A E. Sphingosine-1-phosphate signaling in the cardiovascular system[J]. Curr Opin Pharmacol, 2007, 7(2): 186-192. DOI:10.1016/j.coph.2006.09.008.
WAMHOFF B R, LYNCH K R, MACDONALD T L, et al . Sphingosine-1-phosphate receptor subtypes differentially regulate smooth muscle cell phenotype[J ] . Arterioscler Thromb Vasc Biol, 2008, 28(8): 1454-1461. DOI:10.1161/atvbaha.107.159392.
WANG Y, CHEN D, ZHANG Y, et al . Novel adipokine, FAM19A5, inhibits neointima formation after injury through sphingosine-1-phosphate receptor 2[J ] . Circulation, 2018, 138(1): 48-63. DOI:10.1161/CIRCULATIONAHA.117.032398.
TANIMOTO T, LUNGU A O, BERK B C. Sphingosine 1-phosphate transactivates the platelet-derived growth factor β receptor and epidermal growth factor receptor in vascular smooth muscle cells[J]. Circ Res, 2004, 94(8): 1050-1058. DOI:10.1161/01.res.0000126404.41421.be.
KAPTOGE S, SESHASAI S R, GAO P, et al . Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis[J ] . Eur Heart J, 2014, 35(9): 578-589. DOI:10.1093/eurheartj/eht367.
MORIYA J. Critical roles of inflammation in atherosclerosis[J]. J Cardiol, 2019, 73(1): 22-27. DOI:10.1016/j.jjcc.2018.05.010.
LEE H, DENG J, KUJAWSKI M, et al . STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors[J ] . Nat Med, 2010, 16(12): 1421-1428. DOI:10.1038/nm.2250.
Expression of β-arrestin1 in oral squamous cell carcinoma and its effect on cell proliferation, migration and invasion
Mechanism of CPNE3 regulating proliferation, migration and invasion of non-small cell lung cancer cells
Effect of RNA sensor IFIH1 on proliferation, migration and invasion of HPV positive cervical cancer cells
Effects of endogenous nestin overexpression on proliferation, migration and MAPK signal transduction pathway in NIH3T3 cells
Overexpression of TRIM2 suppresses proliferation, migration and stemness of clear cell renal cell carcinoma cells in vitro
Related Author
HAO Xiaohui
CHEN Min
WU Nan
DING Yunshan
ZHU Lifan
DAI Haitao
Xin CAI
Zeyi LIU
Related Institution
School of Medicine, Shihezi University
Department of Stomatology, the First Affiliated Hospital of Shihezi University
Department of Pulmonary and Critical Care Medicine, Institute of Respiratory Diseases, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Provmce
Institute of Life Sciences, Chongqing Medical University
Department of Pharmacognosy and Traditional Chinese Medicine, Faculty of Pharmacy and Laboratory Medicine, Army Medical University (Third Military Medical University)